Cargando…

PS MD Studies Report No 9: Period 9.10.72 - 4.11.72 (Weeks 41 - 45}

Detalles Bibliográficos
Autor principal:	Barbalat, O
Lenguaje:	eng
Publicado:	1972
Materias:	Accelerators and Storage Rings
Acceso en línea:	http://cds.cern.ch/record/2829518

Ejemplares similares

PS MD Studies Report No 10: Period 8.11 - 2.12.1972 (Weeks 46 - 49)
por: Barbalat, O, et al.
Publicado: (1972)

CPS MD Studies Report No 7: Period 9.8 - 2.9.1972 (Weeks 33 - 36)
por: Barbalat, O, et al.
Publicado: (1972)

PS MD Studies Report No 11: Period 6.12 - 23.12.1973 (Weeks 50 - 52)
por: Barbalat, O, et al.
Publicado: (1973)

PS MO Studies Report No 8: Period 6.9 - 30.9.1972 (Weeks 37 - 40)
por: Barbalat, O, et al.
Publicado: (1972)

Treatment implications of C9ORF72
por: Sha, Sharon J, et al.
Publicado: (2012)

PS MD Studies Report No 15: Period 23.5 - 12,6.1973 (Weeks 21 - 24)
por: Barbalat, O
Publicado: (1973)

PS MD Studies Report No 16: Period June 20 - July 14, 1973 (Weeks 25-28)
por: Barbalat, O, et al.
Publicado: (1973)

PS MD Studies Report No 18: Period August 22 - September 15, 1973 (Weeks 34-37)
por: Barbalat, O, et al.
Publicado: (1973)

PS MD Studies Report No 19: Period September 24 - October 20, 1973 (Weeks 39-42)
por: Barbalat, O, et al.
Publicado: (1973)

PS MD Studies Report No 20: Period October 24 - November 17, 1973 (Weeks 43-46)
por: Barbalat, O, et al.
Publicado: (1973)

PS MD Studies Report No 12: Period 21.2 - 24.3.1973 (Weeks 8 - 14)
por: Barbalat, O, et al.
Publicado: (1973)

PS MD Studies Report No 13: Period 27.3 - 19.4.1973 (Weeks 13 - 16)
por: Barbalat, O, et al.
Publicado: (1973)

PS MD Studies Report No 21: Period November 21 - December 22, 1973 (Weeks 47-51)
por: Barbalat, O, et al.
Publicado: (1974)

Compte Rendu No. 41 - des seances d'etudes sur le PS (MD) et le PSB (ME): Période du 25 février au 21 mars 1976 (Semaines 9 à 12)
por: Barbalat, O, et al.
Publicado: (1976)

Unaffected mosaic C9orf72 case: RNA foci, dipeptide proteins, but upregulated C9orf72 expression
por: McGoldrick, Philip, et al.
Publicado: (2018)

List of PH III experiments, 72-45
por: CERN. Geneva. Physics III Committee
Publicado: (1972)

Neuroimaging features of C9ORF72 expansion
por: Yokoyama, Jennifer S, et al.
Publicado: (2012)

C9orf72 immunohistochemistry in Alzheimer's disease
por: Hortobágyi, Tibor
Publicado: (2012)

The Enigmatic Role of C9ORF72 in Autophagy
por: Nassif, Melissa, et al.
Publicado: (2017)

Erratum: Vol. 72, No. 11
Publicado: (2023)

Neuronal Transcriptome from C9orf72 Repeat Expanded Human Tissue is Associated with Loss of C9orf72 Function
por: Liu, Elaine Y., et al.
Publicado: (2020)

Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
por: Sattler, Rita, et al.
Publicado: (2023)

Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers
por: Frick, Petra, et al.
Publicado: (2018)

The repeat length of C9orf72 is associated with the survival of amyotrophic lateral sclerosis patients without C9orf72 pathological expansions
por: Tang, Lu, et al.
Publicado: (2022)

A comparative bioinformatic analysis of C9orf72
por: Iyer, Shalini, et al.
Publicado: (2018)

RNA Misprocessing in C9orf72-Linked Neurodegeneration
por: Barker, Holly V., et al.
Publicado: (2017)

Compte rendu no 22 - des seances d'etudes sur le PS (MD): Période du 13 février au 9 mars 1974 (Semaines 7 à 10)
por: Barbalat, O, et al.
Publicado: (1974)

Compte rendu no. 72 des seances d,etude sur le ps (md) et le booster (me)
por: Brouzet, E, et al.
Publicado: (1980)

The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway
por: Sullivan, Peter M., et al.
Publicado: (2016)

C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers
por: Rizzu, Patrizia, et al.
Publicado: (2016)

Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features
por: Lorenzini, Ileana, et al.
Publicado: (2023)

Assessment of psychiatric changes in C9ORF72 frontotemporal dementia
por: Hornberger, Michael
Publicado: (2012)

C9ORF72 expansion in a family with bipolar disorder
por: Meisler, Miriam H, et al.
Publicado: (2013)

Age-related penetrance of the C9orf72 repeat expansion
por: Murphy, Natalie A., et al.
Publicado: (2017)

Gyrification abnormalities in presymptomatic c9orf72 expansion carriers
por: Caverzasi, Eduardo, et al.
Publicado: (2019)

Correction to Lancet Glob Health 2021; 9: e759–72
Publicado: (2021)

C9ORF72: What It Is, What It Does, and Why It Matters
por: Smeyers, Julie, et al.
Publicado: (2021)

FDG-PET in presymptomatic C9orf72 mutation carriers
por: Popuri, Karteek, et al.
Publicado: (2021)

C9ORF72 suppresses JAK-STAT mediated inflammation
por: Pang, Weilun, et al.
Publicado: (2023)

Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion()
por: Waite, Adrian J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ttke52td25u15gimu4rpi11sl1